TY - JOUR
T1 - Predictive factors for an uncomplicated long-term course of Crohn's disease
T2 - A retrospective analysis
AU - Kruis, W.
AU - Katalinic, A.
AU - Klugmann, T.
AU - Franke, G. R.
AU - Weismüller, J.
AU - Leifeld, L.
AU - Ceplis-Kastner, S.
AU - Reimers, B.
AU - Bokemeyer, B.
PY - 2013/6/11
Y1 - 2013/6/11
N2 - Background: Predictive factors for a mild course of Crohn's disease (CD) may have therapeutic consequences, but as yet have not been identified. Aims: To identify baseline factors that predict mild CD and design a predictive scoring system. Methods: A retrospective, multicenter study of newly diagnosed CD patients allocated to mild CD (no therapy, mesalazine only, or mesalazine with a single initial short course of low-dose prednisone) or moderate CD (all other patients including resected patients). Results: 162 patients (median follow-up 43. months) were analyzed: 47 mild CD and 115 moderate CD. For mild CD versus moderate CD, mean age at first diagnosis was higher (41.1 versus 33.9. years, p=0.02), mean C-reactive protein (CRP) concentration was lower (1.6 versus 3.6. mg/L, p < 0.01), and perianal lesions were less frequent (0% versus 10.4%, p=0.02). The combined incidence of complications (stenosis, any type of fistula, extraintestinal complications or fever) was 21.3% in mild CD versus 35.7% in moderate CD (p=0.07). A scoring system based on age, CRP, endoscopic severity (adapted Rutgeert's score), perianal lesions and combined incidence of complications was developed which can predict a mild prognosis at the initial diagnosis, giving patients the chance of simplified therapy and accelerated step-up in the event of treatment failure. Conclusions: Approximately a third of CD patients experience a mild disease course and require only basic therapy. A possible scoring system to predict mild CD which may avoid overtreatment and unnecessary risks for the patient and costs is suggested.
AB - Background: Predictive factors for a mild course of Crohn's disease (CD) may have therapeutic consequences, but as yet have not been identified. Aims: To identify baseline factors that predict mild CD and design a predictive scoring system. Methods: A retrospective, multicenter study of newly diagnosed CD patients allocated to mild CD (no therapy, mesalazine only, or mesalazine with a single initial short course of low-dose prednisone) or moderate CD (all other patients including resected patients). Results: 162 patients (median follow-up 43. months) were analyzed: 47 mild CD and 115 moderate CD. For mild CD versus moderate CD, mean age at first diagnosis was higher (41.1 versus 33.9. years, p=0.02), mean C-reactive protein (CRP) concentration was lower (1.6 versus 3.6. mg/L, p < 0.01), and perianal lesions were less frequent (0% versus 10.4%, p=0.02). The combined incidence of complications (stenosis, any type of fistula, extraintestinal complications or fever) was 21.3% in mild CD versus 35.7% in moderate CD (p=0.07). A scoring system based on age, CRP, endoscopic severity (adapted Rutgeert's score), perianal lesions and combined incidence of complications was developed which can predict a mild prognosis at the initial diagnosis, giving patients the chance of simplified therapy and accelerated step-up in the event of treatment failure. Conclusions: Approximately a third of CD patients experience a mild disease course and require only basic therapy. A possible scoring system to predict mild CD which may avoid overtreatment and unnecessary risks for the patient and costs is suggested.
UR - http://www.scopus.com/inward/record.url?scp=84878650860&partnerID=8YFLogxK
U2 - 10.1016/j.crohns.2012.10.012
DO - 10.1016/j.crohns.2012.10.012
M3 - Journal articles
C2 - 23182164
AN - SCOPUS:84878650860
SN - 1873-9946
VL - 7
JO - Journal of Crohn's and Colitis
JF - Journal of Crohn's and Colitis
IS - 7
ER -